Holen Sie sich die Stockscreener-App
24.14
1.51%
-0.3482
Finanzdaten der Beam Therapeutics Inc-Aktie (BEAM)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
97.66%
7.41
|
316.19 | 17.19 | 20.12 | 24.21 |
Operating Expenses
|
39.16%
111.54
|
183.33 | 125.46 | 122.26 | 123.14 |
| Benefits Costs and Expenses |
38.34%
106.08
|
172.03 | 113.28 | - | 120.67 |
| Costs And Expenses |
38.34%
106.08
|
172.03 | 113.28 | 122.26 | 120.67 |
| Operating Income/Loss |
178.38%
-104.13
|
132.86 | -108.27 | -102.15 | -98.93 |
| Nonoperating Income/Loss |
51.68%
5.463
|
11.30 | 12.18 | 19.37 | 2.468 |
| Income/Loss From Continuing Operations Before Tax |
168.44%
-98.67
|
144.16 | -96.09 | -82.78 | -96.46 |
| Income Tax Expense/Benefit |
100.00%
-
|
1.366 | - | - | - |
| Income/Loss From Continuing Operations After Tax |
169.10%
-98.67
|
142.80 | -96.09 | -82.78 | -96.46 |
|
Net Income/Loss
|
169.10%
-98.67
|
142.80 | -96.09 | -82.78 | -96.46 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
6,440%
81.70
|
1.2492 | 79.02 | 76.34 | 72.27 |
| Diluted Average Shares |
6,440%
81.70
|
1.2492 | 79.02 | 76.34 | 72.27 |
| Basic Earnings Per Share |
163.35%
-1.21
|
1.91 | -1.22 | -1.08 | -1.33 |
| Diluted Earnings Per Share |
163.35%
-1.21
|
1.91 | -1.22 | -1.08 | -1.33 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.80%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):